tiprankstipranks
Acurx Pharmaceuticals (ACXP)
NASDAQ:ACXP
US Market
ACXP
Acurx Pharmaceuticals
RESEARCH TOOLSreports
Want to see ACXP full AI Analyst Report?

Acurx Pharmaceuticals (ACXP) Income Statement

358 Followers

Acurx Pharmaceuticals Income Statement

Last quarter (Q4 2025), Acurx Pharmaceuticals's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q4, Acurx Pharmaceuticals's net income was $-1.58M. See Acurx Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 8.09M$ 14.10M$ 14.58M$ 12.09M$ 12.81M
Depreciation and Amortization
$ 0.00$ 14.10M$ 0.00$ 0.00$ 0.00
EBITDA
$ -8.09M$ 0.00$ -14.58M$ -12.09M$ -12.81M
Operating Income
$ -8.09M$ -14.10M$ -14.58M$ -12.09M$ -12.81M
Other Income/Expenses
$ 125.44K-$ 0.00$ 0.00$ 66.50K
Pretax Income
$ -7.97M$ -14.10M$ -14.58M$ -12.09M$ -12.75M
Net Income
$ -7.97M$ -14.10M$ -14.58M$ -12.09M$ -12.75M
Per Share Metrics
Basic EPS
$ -5.32$ -17.59$ -23.01$ -22.36$ -24.96
Diluted EPS
$ -5.32$ -17.59$ -23.01$ -22.36$ -24.96
Weighted Average Shares Outstanding
 1.50M 851.55K 633.60K 540.80K 510.80K
Weighted Average Shares Outstanding (Diluted)
 1.50M 851.55K 633.60K 540.80K 510.80K
Currency in USD

Acurx Pharmaceuticals Earnings and Revenue History